Early diagnosis of HPV16 cancers: a novel assay offers high specificity

The incidence of virus-related head and neck tumours is reaching epidemic proportions, particularly in the developed world. Here, Anna Huber (Abviris Scientific Affairs) provides an overview and discusses the need to improve patient outcomes while also offering cost-savings to the NHS.